Replies to post #62 on Medgenics (MDGN)

[bob smith]

absolutely nothing in the long term.

it was generic excerpt from a 42 page filing thats seen in every 8-k.


look for support and entry....!

The number of shares of our common stock that will be outstanding immediately after this offering is based on 12,307,808 shares of common stock outstanding as of December 31, 2012, and excludes:
1,059,542 shares of our common stock issuable upon the exercise of stock options outstanding under our Stock Incentive Plan as of December 31, 2012, at a weighted-average exercise price of $5.17 per share, 914,219 of which were exercisable as of that date;
900,000 shares of our common stock issuable upon the exercise of stock options granted to our Chairman of the Board outside of our Stock Incentive Plan, having an exercise price of $10.80 per share, 300,000 of which were exercisable as of that date;

929,152 shares of our common stock reserved for issuance under our Stock Incentive Plan as of December 31, 2012; 5,969,891 shares of our common stock issuable upon the exercise of outstanding warrants as of December 31, 2012, at a weighted-average exercise price of $5.93 per share, all of which were exercisable as of that date; and shares of our common stock issuable upon exercise of the Series 2013-A warrants to be issued in this offering.

Except as otherwise indicated, all information in this prospectus supplement assumes no exercise by the underwriters of their option to purchase additional shares and/or Series 2013-A warrants to cover over-allotments, if any.


gl